Skip to Main Content
Contribute Try STAT+ Today

Tech giants are stepping up to the plate to play a part in the coronavirus pandemic response, tapping into their wide-ranging resources to help experts get a handle on the spread of the virus and to fill in gaps in the government’s response. But it’s not clear yet how — or to what extent — those efforts could help bring the crisis under control.

In recent weeks, major tech companies have publicized stronger efforts to police misinformation on their platforms, rolled out testing and triage tools, and donated masks and other medical supplies. They’re helping health officials share accurate information and providing academic researchers with massive data sets to help predict the spread of the virus or forecast its impact on hospitals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.